This is the text extract for March Tender Notification; Contact: Kyle Reid, browse documents here.

---

31 March 2011

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2009/10 Invitation to Tender, dated 4 December 2010 and the 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we intend to notify tender decisions as they are made in 2011. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. We have, therefore, altered the layout of this notification letter. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp.

A415547 - qA18036

---

2009/10 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2013 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to an unlisted pharmaceutical.

Presentation; Pack size and type Tab 0.125 mg; 30 tablets, blister Tab 0.25 mg; 30 tablets, blister Tab 1 mg; 30 tablets, blister Subsidy and price Sole supply brand (Supplier) Dr Reddy’s Pramipexole (Dr Reddy’s) Dr Reddy’s Pramipexole (Dr Reddy’s) Dr Reddy’s Pramipexole (Dr Reddy’s) Listing date Sole Subsidised Supply date

Chemical name Pramipexole hydrochloride Pramipexole hydrochloride Pramipexole hydrochloride

$1.95

1 September 2011

1 December 2011

$2.40

1 September 2011

1 December 2011

$7.20

1 September 2011

1 December 2011

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Tab 0.125 mg; 30 tablets, blister Tab 0.25 mg; 30 tablets, blister Tab 1 mg; 30 tablets, blister Hospital Supply Brand (Supplier) Dr Reddy’s Pramipexole (Dr Reddy’s) Dr Reddy’s Pramipexole (Dr Reddy’s) Dr Reddy’s Pramipexole (Dr Reddy’s) DV Limit 1%

The decisions were as follows:

Chemical Name Pramipexole hydrochloride Pramipexole hydrochloride Pramipexole hydrochloride

Pack price

Listing date

Hospital Supply Status date

$1.95

1 September 2011

1 November 2011

$2.40

1%

1 September 2011

1 November 2011

$7.20

1%

1 September 2011

1 November 2011

A415547 - qA18036

---

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

3. Tenders awarded to an unlisted pharmaceutical.

Presentation; Pack size and type Powder; 5 g, bottle Subsidy and price $42.50 Sole supply brand (Supplier) Midwest (Midwest) Listing date 1 July 2011 Sole Subsidised Supply date 1 October 2011

Chemical name Omeprazole*

* Omeprazole powder will be listed in Section B of the Pharmaceutical Schedule as “Only in combination” with the following restriction: a) Only in extemporaneously compounded omeprazole suspension.

4.

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and price $47.81 $2.28 $110.00 $2.21 $3.78 New subsidy and price $38.24 $1.96 $110.00 $1.59 $2.34

The decisions were as follows:

Chemical name Amantadine hydrochloride Aqueous cream Calcitonin Cetirizine hydrochloride Citalopram hydrobromide

Presentation; Pack size and type Cap 100 mg; 60 capsules, bottle Cream; 500 g, bottle Inj 100 iu per ml, 1 ml; 5 ampoules Tab 10 mg; 100 tablets, foil Tab 20 mg; 84 tablets; blister

Sole supply brand (Supplier) Symmetrel (Novartis) AFT (AFT) Miacalcic (Novartis) Zetop (Arrow) Arrow-Citalopram (Arrow) Ginet-84 (Rex) Desmopressin PH&T (AFT)

Date of subsidy change

Sole Subsidised Supply date

1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

Tab 2 mg with ethinyloestradiol Cyproterone 35 mcg and 7 inert tablets; acetate with ethinyloestradiol 84 tablets; blister Desmopressin Nasal spray 10 mcg per dose; 6 ml OP, bottle

$4.91

$3.89

1 July 2011

1 October 2011

$29.94

$27.48

1 July 2011

1 October 2011

A415547 - qA18036

---

Doxycycline hydrochloride Gliclazide Omeprazole Pyridoxine hydrochloride* Pyridoxine hydrochloride Simvastatin Simvastatin Simvastatin Simvastatin Tramadol hydrochloride

Tab 100 mg; 250 tablets, bottle Tab 80 mg; 500 tablets, bottle Inj 40 mg; 5 injections Tab 25 mg; 90 tablets, bottle Tab 50 mg; 500 tablets, bottle Tab 10 mg; 90 capsules; blister Tab 20 mg; 90 capsules; blister Tab 40 mg; 90 capsules; blister Tab 80 mg; 90 capsules; blister Cap 50 mg; 100 capsules, blister

$8.10 $22.24 $38.20 $3.06** $17.63 $2.05 $3.00 $5.35 $11.65 $6.95

$7.95 $17.60 $28.65 $2.20 $12.16 $1.40 $1.95 $3.18 $9.31 $4.95

Doxine (Mylan) Apo-Gliclazide (Apotex) Dr Reddy’s Omeprazole PyridoxADE (Boucher and Muir) Apo-Pyridoxine (Apotex) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Tramadol (Arrow)

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

* Although the Healtheries brand of pyridoxine 25 mg tablet is currently listed in the Pharmaceutical Schedule, this was discontinued on 1 February 2011 and will be delisted on 1 August 2011. ** Subsidy currently applicable to Healtheries brand of pyridoxine hydrochloride 25 mg tablet.

A415547 - qA18036

---

5.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

Date of listing/subsidy change for tender winning brand 1 August 2011 Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 January 2012 Dr Reddy’s Omeprazole (Dr Reddy’s) Dr Reddy’s Omeprazole (Dr Reddy’s) Dr Reddy’s Omeprazole (Dr Reddy’s) Pravachol (Sigma) Pravachol (Sigma)

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Cap 10 mg; 90 capsules, bottle Cap 20 mg; 90 capsules, bottle Cap 40 mg; 90 capsules, bottle Tab 20 mg; 30 tablets, blister Tab 40 mg; 30 tablets, blister

Current subsidy and price $2.14 (30 caps) $3.05 (30 caps) $3.59 (30 caps) $42.58 $65.31

New subsidy and price

Sole supply brand (Supplier)

Date of reference pricing of other listed brands

Omeprazole

$2.91

Omezol Relief (Mylan) Omezol Relief (Mylan) Omezol Relief (Mylan) Cholvastin (Douglas) Cholvastin (Douglas)

1 October 2011

Omeprazole

$3.78

1 August 2011

1 October 2011

1 January 2012

Omeprazole

$5.57

1 August 2011

1 October 2011

1 January 2012

Pravastatin Pravastatin

$5.44 $9.28

1 September 2011 1 September 2011

1 November 2011 1 November 2011

1 February 2012 1 February 2012

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 6. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Powder; 5 g, bottle Tab 20 mg; 30 tablets, blister Hospital Supply Brand (Supplier) Midwest (Midwest) Cholvastin (Douglas) DV Limit 1% 1%

The decisions were as follows:

Chemical Name Omeprazole Pravastatin

Pack price $42.50 $5.44

Listing date 1 July 2011 1 September 2011

Hospital Supply Status date 1 September 2011 1 November 2011

A415547 - qA18036

---

Pravastatin Pyridoxine hydrochloride Pyridoxine hydrochloride

Tab 40 mg; 30 tablets, blister Tab 25 mg; 90 tablets, bottle Tab 50 mg; 500 tablets, bottle

$9.28 $2.20 $12.16

Cholvastin (Douglas) PyridoxADE (Boucher and Muir) Apo-Pyridoxine (Apotex)

1% 1% 1%

1 September 2011 1 July 2011 1 July 2011

1 November 2011 1 September 2011 1 September 2011

7.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Presentation; Pack size and type Cream; 100 g, bottle Cream; 500 g, bottle Cap 100 mg; 60 capsules, bottle Inj 100 iu per ml, 1 ml; 5 ampoules Tab 10 mg; 100 tablets, foil Tab 20 mg; 84 tablets; blister Nasal spray 10 mcg per dose; 6 ml OP, bottle Inj 20 mg; 1 vial Inj 80 mg; 1 vial Current pack price $1.49 $2.28 $47.81 $110.00 $2.21 $3.78 New pack price $1.23 $1.96 $38.24 $110.00 $1.59 $2.34 Hospital Supply Brand (Supplier) AFT (AFT) AFT (AFT) Symmetrel (Novartis) Miacalcic (Novartis) Zetop (Arrow) Arrow-Citalopram (Arrow) Desmopressin PH&T (AFT) Docetaxel Ebewe (Sandoz) Docetaxel Ebewe (Sandoz) DV Limit 1% 1% 1% 1% 1% 1%

The decisions were as follows:

Chemical Name Aqueous cream Aqueous cream Amantadine hydrochloride Calcitonin Cetirizine hydrochloride Citalopram hydrobromide Desmopressin

Date of price change 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

Hospital Supply Status date 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

$29.94

$27.48

1%

1 July 2011

1 September 2011

Docetaxel* Docetaxel*

$325.00 $1300.00

$48.75 $195.00

1% 1%

1 July 2011 1 July 2011

1 September 2011 1 September 2011

A415547 - qA18036

---

Doxycycline hydrochloride Gliclazide

Tab 100 mg; 250 tablets, bottle Tab 80 mg; 500 tablets, bottle Inj 40 mg; 5 injections Inf 40 mg; 5 infusions Tab 10 mg; 90 capsules; blister Tab 20 mg; 90 capsules; blister Tab 40 mg; 90 capsules; blister Tab 80 mg; 90 capsules; blister Cap 50 mg; 100 capsules, blister

$8.10 $22.24

$7.95 $17.60

Doxine (Mylan) Apo-Gliclazide (Apotex) Dr Reddy’s Omeprazole (Dr Reddy’s) Dr Reddy’s Omeprazole (Dr Reddy’s) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Simva (Arrow) Arrow-Tramadol (Arrow)

1% 1%

1 July 2011 1 July 2011

1 September 2011 1 September 2011

Omeprazole

$38.20

$28.65

1%

1 July 2011

1 September 2011

Omeprazole

$38.65

$19.00

1%

1 July 2011

1 September 2011

Simvastatin Simvastatin Simvastatin Simvastatin Tramadol hydrochloride

$2.05 $3.00 $5.35 $11.65 $6.95

$1.40 $1.95 $3.18 $9.31 $4.95

1% 1% 1% 1% 1%

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

* The price and subsidy of docetaxel (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 July 2011. The subsidy for docetaxel 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $17.55 per 1 mg to $2.63 per 1 mg from 1 July 2011.

8.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Cap 10 mg; 90 capsules, bottle Current pack price $2.14 (30 caps) New pack price $2.91 Hospital Supply Brand (Supplier) Omezol Relief (Mylan) DV Limit 1% Date of listing/price change for tender winning brand 1 August 2011 Hospital Supply Status date (and delisting of other listed brands) 1 October 2011 Brand (Supplier) to be delisted Dr Reddy’s Omeprazole (Dr Reddy’s)

The decisions were as follows:

Chemical Name

Omeprazole

A415547 - qA18036

---

Chemical Name

Presentation; Pack size and type Cap 20 mg; 90 capsules, bottle Cap 40 mg; 90 capsules, bottle

Current pack price $3.05 (30 caps) $3.59 (30 caps)

New pack price $3.78

Hospital Supply Brand (Supplier) Omezol Relief (Mylan) Omezol Relief (Mylan)

DV Limit 1%

Date of listing/price change for tender winning brand 1 August 2011

Hospital Supply Status date (and delisting of other listed brands) 1 October 2011

Brand (Supplier) to be delisted Dr Reddy’s Omeprazole (Dr Reddy’s) Dr Reddy’s Omeprazole (Dr Reddy’s)

Omeprazole

Omeprazole

$5.57

1%

1 August 2011

1 October 2011

A415547 - qA18036

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Apomorphine hydrochloride Apomorphine hydrochloride Bezafibrate Budesonide Buspirone hydrochloride Buspirone hydrochloride Calcipotriol Calcipotriol Calcipotriol Calcipotriol Calcium folinate Cladribine Co-trimoxazole Cyclizine hydrochloride Danazol Danazol Desmopressin Desmopressin Dipyridamole Domperidone Dothiepin hydrochloride Dothiepin hydrochloride Line Item Inj 10 mg per ml, 1 ml Inj 10 mg per ml, 2 ml Tab 200 mg Cap 3 mg modified release Tab 10 mg Tab 5 mg Crm 50 mcg per g (pack size 30 g or less) Crm 50 mcg per g (pack size greater than 30 g) Soln 50 mcg per ml (pack size 30 ml or less) Soln 50 mcg per ml (pack size greater than 30 ml) Inj 3 mg Inj 10 mg Tab 80 mg and sulphamethoxazole 400 mg Oral liq 12.5 mg per 5 ml Cap 100 mg Cap 200 mg Inj 4 mcg per ml, 1 ml Nasal drops 100 mcg per ml Tab 25 mg Oral liq 1 mg per ml Cap 25 mg Tab 75 mg Chemical Name Ketoprofen Ketoprofen Lithium Citrate Lithium Citrate Mebendazole Menadione sodium bisulphite Mesalazine suppos Methyldopa Methyldopa Methyldopa Nicotinic acid Nicotinic acid Nicotinic acid Nicotinic acid Oxycodone hydrochloride Oxycodone hydrochloride Oxycodone hydrochloride Oxycodone hydrochloride Oxycodone hydrochloride Penicillamine Penicillamine Phenobarbitone Line Item Cap long-acting 100 mg Cap long-acting 200 mg Oral liquid (approx. 10.8 mmol lithium ion per 5 ml) Oral liquid (approx. 5.4 mmol lithium ion per 5 ml) Oral liq 100 mg per 5 ml Tab 10 mg 1g Tab 125 mg Tab 250 mg Tab 500 mg Tab modified-release 375 mg Tab modified-release 500 mg Tab modified-release 750 mg Tab modified-release 1 g Tab controlled-release 5 mg Tab controlled-release 10 mg Tab controlled-release 20 mg Tab controlled-release 40 mg Tab controlled-release 80 mg Tab 125 mg Tab 250 mg Oral liq 15 mg per 5 ml

A415547 - qA18036

---

Eletriptan Eletriptan Eletriptan Flumetasone pivalate Foscarnet Galantamine Galantamine Galantamine Heparinised saline Heparinised saline Heparinised saline Indomethacin Indomethacin Indomethacin Indomethacin

Tab 20 mg Tab 40 mg Tab 80 mg Ear drops 0.02% with clioquinol 1% Inj 24 mg per ml Cap 4 mg Cap 8 mg Cap 12 mg Inj 100 iu per ml, 2 ml ampoule Inj 100 iu per ml, 5 ml ampoule Inj 100 iu per ml, 2 ml prefilled syringe Cap 25 mg Cap 50 mg Cap long-acting 75 mg Inj 1 mg

Phytomenadione Phytomenadione Propranolol Propranolol Risedronate sodium Risedronate sodium Risedronate sodium Risedronate sodium Streptokinase Streptokinase Testosterone Testosterone Trimethoprim Trimethoprim Trimethoprim

Tab 2 mg or less Tab 10 mg Tab 10 mg Tab 40 mg Tab 5 mg Tab 30 mg Tab 35 mg Tab 150 mg Inj 250,000 IU Inj 1,500,000 IU Transdermal patch 2.5 mg Transdermal patch 5 mg Oral liq Tab 100 mg Tab 300 mg

For products included in the 2008/09 Invitation to Tender, 2009/10 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A415547 - qA18036